The cGAS-STING pathway as a therapeutic target in inflammatory diseases.
Alexiane Decout, Jason D Katz, Shankar Venkatraman...
https://pubmed.ncbi.nlm.nih.gov/33833439/Actively Recruiting
Led by Zhongda Hospital · Updated on 2026-06-11
80
Participants Needed
1
Research Sites
4 weeks
Total Duration
Atopic dermatitis AD, also known as eczema, is a chronic skin condition marked by intense itching and skin barrier damage caused by an overactive immune system. Researchers are investigating the role of circulating cell-free DNA cfDNA as a potential trigger in this disease. This study aims to compare cfDNA levels in blood between people with AD and healthy volunteers, and to explore how skin immune cells respond to this DNA by activating the STING pathway. Participants include individuals diagnosed with AD and healthy volunteers. Researchers will collect blood samples and, for some AD patients, small skin biopsies to analyze cfDNA levels and immune cell activity. The study will measure the density of skin macrophages expressing STING protein and assess disease severity using skin scoring methods such as SCORAD and EASI. During the study, participants will undergo dermatological evaluations and provide samples for laboratory analysis. Researchers will use these data to explore connections between cfDNA levels, skin immune responses, and AD severity. The study helps to understand disease mechanisms that may improve future monitoring and treatment approaches. Participation lasts according to study schedules until primary outcome data collection is complete.
CONDITIONS
Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Zhongda Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - One-time or as scheduled during study period
Participants provide blood samples and, if eligible, skin biopsies for research. Dermatological assessments are performed to measure disease severity.
1 or more visits depending on group assignment
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alexiane Decout, Jason D Katz, Shankar Venkatraman...
https://pubmed.ncbi.nlm.nih.gov/33833439/Ling Dong, Yue-Ru Hou, Na Xu...
https://pubmed.ncbi.nlm.nih.gov/39112770/Charles F Schuler, Lam C Tsoi, Allison C Billi...
https://pubmed.ncbi.nlm.nih.gov/38085213/Verena Kopfnagel, Sylvia Dreyer, Jana Zeitvogel...
https://pubmed.ncbi.nlm.nih.gov/34176149/Zhongda Hospital
Lead Sponsor